JPRN-UMIN000001905尚未招募未知
se of micafungin as antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation. - Use of micafungin as antifungal prophylaxis in patients undergoing hematopoietic stem cell transplantation.
适应症
试验速览
- 阶段
- 未知
- 状态
- 尚未招募
- 入组人数
- 65
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 65years-old（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Patients are free of fungal infection at the time of enrollment. Patients have a history of a serious allergy to the study drug. Patients have a serious liver dysfunction. Patients have received micafungin within 7 days before the time of enrollment.
研究者
相似试验
进行中（未招募）
不适用
Antifungal prophylaxis with Micafungin after cord blood allogeneic stem cell transplantation.EUCTR2013-000103-16-FRCHU de Nantes
已完成
1 期
Alternate Day Micafungin: A PK Study in Pediatric PatientsFungal InfectionNCT00842504Children's Hospital Medical Center, Cincinnati15
已完成
2 期
Micafungin Prophylaxis During 1st Induction Chemotherapy for De Novo Acute LeukemiaAcute LeukemiaNCT02440178Seoul National University Hospital66
已完成
不适用
sefulness of micafungin in the empiric therapy of invasive fungal infections in surgery and intensive-care medicinePatients undergoing gastroenterological surgeryJPRN-UMIN000011388Department of infectious disease, Hiroshima University Hospital65
进行中（未招募）
1 期
Exposure to micafungin given twice/week compared to once/day.prophylaxis for patients at high risk for invasive fungal diseasesMedDRA version: 17.0Level: PTClassification code 10017533Term: Fungal infectionSystem Organ Class: 10021881 - Infections and infestationsEUCTR2013-002848-93-BERadboud University Medical Centre20